Search

Displaying results 8861 - 8870 of 10000 in total
  1. Drug

    Neopterin

    go.drugbank.com/drugs/DB15050
    Investigational

    Neopterin is under investigation in clinical trial NCT02974192 (Neopterin Effects on Ischemic Stroke).

  2. Drug

    Amylose

    go.drugbank.com/drugs/DB15216
    Investigational

    Amylose is under investigation in clinical trial NCT01027325 (Resistant Starch Insulin Sensitivity Trial).

  3. Drug

    ZKN-013

    go.drugbank.com/drugs/DB32582
    Experimental

    ZKN-013 is a readthrough inducer under investigation for rare dermatological diseases.[L56075]

  4. Drug

    AZD-8965

    go.drugbank.com/drugs/DB32868
    Experimental

    AZD-8965 is a small molecule inhibitor of ARG-1 and ARG-2.

  5. Drug

    D-Glutamic Acid

    go.drugbank.com/drugs/DB02517
    Experimental

    Glutamic acid is the most common excitatory neurotransmitter in the central nervous system.

  6. Drug

    D-Cysteine

    go.drugbank.com/drugs/DB03201
    Experimental

    A thiol-containing non-essential amino acid that is oxidized to form CYSTINE.

    Synonyms: (2S)-2-amino-3-mercaptopropanoic acid, (2S)-2-amino-3-sulfanylpropanoic acid
  7. Drug

    (R)-Rolipram

    go.drugbank.com/drugs/DB04149
    Investigational

    The (R)-enantiomer of rolipram, it is a phosphodiesterase inhibitor with antidepressant properties.

  8. Drug

    Homocysteine

    go.drugbank.com/drugs/DB04422
    Investigational

    Homocysteine is a thiol-containing amino acid formed by a demethylation of methionine.

  9. Drug

    Nutlin-3

    go.drugbank.com/drugs/DB17039
    Experimental

    Nutlin-3 is a small molecule inhibitor that targets p53-Mdm2 interaction.[A253057]

    Synonyms: 2-piperazinone, 4-(((4r,5s)-4,5-bis(4-chlorophenyl)-4,5-dihydro-2-(4-methoxy-2-(1-methylethoxy)phenyl)-1h-imidazol-1-yl)carbonyl)-, rel-
  10. Drug

    RO7284755

    go.drugbank.com/drugs/DB17527
    Investigational

    RO7284755 is an investigational cancer drug: it is a PD-1-targeted IL-2 variant antibody fusion protein. … RO7284755 is under investigation in clinical trial NCT04303858 (A Study to Evaluate Safety and Anti-tumor Activity of RO7284755 Alone or in Combination With Atezolizumab in Participants With Advanced And